Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Safe Supply Streaming Co Ltd C.SPLY

Alternate Symbol(s):  SSPLF

Safe Supply Streaming Co Ltd. is focused on the acquisition, investment, and development of businesses within the medical, wellness, and technology sectors. It has a diversified portfolio of companies and investments encompassing equity, debt, and partnerships that stretch across the entire medical technologies and artificial intelligence (AI) healthcare spectrum. It invests in the burgeoning... see more

Recent & Breaking News (CSE:SPLY)

SAFE SUPPLY AND ORIGIN THERAPEUTICS ANNOUNCES ENGAGEMENT OF RESEARCH CAPITAL AND UPSIZING OF BROKERED FINANCING TO $4 MILLION

GlobeNewswire March 2, 2023

Origin Enters into Binding Letter of Intent with Safe Supply Streaming Co., a Pharmaceutical and Narcotics Investment Company with a First Mover Advantage in the Safe Supply Narcotics Sector

GlobeNewswire January 31, 2023

IIROC Trading Halt - ORIG

Canada NewsWire January 31, 2023

Origin Therapeutics Announces New Director

GlobeNewswire October 31, 2022

Origin Therapeutics' (CSE:ORIG) portfolio company Clairvoyant approved for Phase 2 Psilocybin Therapy Trial

John Ballem  October 19, 2022

Origin Therapeutics' Portfolio Company, Clairvoyant, Approved for Phase 2 Psilocybin Therapy Trial; First Clinical Site Initiated in Finland

GlobeNewswire October 18, 2022

Origin Therapeutics Announces Director Resignation

GlobeNewswire October 3, 2022

Origin Therapeutics' (CSE:ORIG) Xpira Pharmaceuticals receive FDA approval for psilocybin

Sabrina Cuthbert September 22, 2022

Origin Therapeutics' Portfolio Company, Xpira Pharmaceuticals, Receives FDA Approval For Psilocybin Trial IND Application

GlobeNewswire September 22, 2022

Origin Therapeutics (CSE:ORIG) appoints new director

Shoran Devi September 9, 2022

Origin Therapeutics Announces New Director

GlobeNewswire September 9, 2022

Canadian Securities Exchange Reports June 2022 Performance Figures

Newsfile July 15, 2022

Origin Therapeutics (CSE:ORIG) adds Clairvoyant Therapeutics to its portfolio

Azuka Onwuka July 7, 2022

Origin Therapeutics adds Clairvoyant Therapeutics to its Portfolio

GlobeNewswire July 7, 2022

UPDATE - Origin Therapeutics Applauds Incoming Decriminalization for Potential to Reduce Stigma

GlobeNewswire June 14, 2022